Fredun Pharmaceuticals Limited (NSE:FREDUN)
India · Delayed Price · Currency is INR 1,519.40
-2.00 (-0.13%)
At close: Nov 9, 2026
Fredun Pharmaceuticals Market Cap
Fredun Pharmaceuticals has a market cap or net worth of 25.12 billion as of November 10, 2026. Its market cap has increased by 242.92% in one year.
Market Cap
25.12B
Enterprise Value
27.09B
Revenue
8.66B
Global Rank
n/a
Country Rank
n/a
PE Ratio
54.94
ChartMarket Cap Chart
Since March 28, 2016, Fredun Pharmaceuticals's market cap has increased from 29.40M to 25.12B, an increase of 85,320.93%. That is a compound annual growth rate of 88.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 25.12B | 237.06% |
| Dec 31, 2025 | 7.45B | 115.10% |
| Dec 31, 2024 | 3.46B | -15.14% |
| Dec 29, 2023 | 4.08B | -20.69% |
| Dec 30, 2022 | 5.15B | 37.31% |
| Dec 31, 2021 | 3.75B | 116.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 51.86B |
| RPG Life Sciences | 42.33B |
| Solara Active Pharma Sciences | 30.54B |
| Ind-Swift Laboratories | 30.11B |
| Sakar Healthcare | 21.69B |
| Windlas Biotech | 20.59B |
| Indoco Remedies | 19.85B |
| Beta Drugs | 18.31B |